Heart & Health Study
NCT00536185 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 166
Last updated 2026-03-25
Summary
We hope to learn more about why certain people have higher levels of the 5-LO protein and whether taking fish oil supplements gives such individuals greater protection than others against cardiovascular disease. The 5-LO protein is important in the development of heart disease because it converts a type of oil from meat into a compound that can cause inflammation in blood vessels. This inflammation is a major cause of heart disease.
Researchers think that people with higher levels of a protein called 5-LO in their white blood cells may have a healthier response to using fish oil supplements than do people with lower levels of this protein.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Fish Oil
capsules, 5.0 g/d fish oil concentrate (3.0 g/d EPA + DHA), 6 weeks
- DIETARY_SUPPLEMENT
-
Placebo
capsule, 5.0 g/d corn/soybean oil (50/50 mixture), 6 weeks
Sponsors & Collaborators
-
National Center for Complementary and Integrative Health (NCCIH)
collaborator NIH -
Office of Dietary Supplements (ODS)
collaborator NIH -
University of California, Davis
collaborator OTHER -
USDA Beltsville Human Nutrition Research Center
collaborator FED -
Alta Bates Summit Medical Center
collaborator OTHER -
University of Southern California
collaborator OTHER -
USDA, Western Human Nutrition Research Center
lead FED
Principal Investigators
-
Charles B Stephensen, PhD · UC Davis & U.S. Department of Agriculture
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 59 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-12-31
- Primary Completion
- 2008-07-31
- Completion
- 2008-07-31
Countries
- United States
Study Locations
More Related Trials
-
Effect of a Mediterranean Diet and Omega-3 Fatty Acids on Oxidative Stress and Endothelial Progenitor Cells (EPC's)
NCT00166088 ·Status: COMPLETED ·Phase: PHASE2
-
Vascular Impact of Omega-3 in Metabolic Syndrome
NCT01566188 ·Status: COMPLETED ·Phase: NA
-
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids
NCT01624727 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega-3 Docosapentaenoic Acid on Lipids and Other Risk Factors for Cardiovascular Disease
NCT04088240 ·Status: TERMINATED ·Phase: NA
-
Fish Oil to Prevent Asthma Exacerbations in Patients With ALOX5 Polymorphisms
NCT00621829 ·Status: COMPLETED ·Phase: NA
-
Genes, Omega-3 Fatty Acids and Cardiovascular Disease Risk Factors
NCT01343342 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effects of Omega-3 Fatty Acids on Metabolic Syndrome
NCT00350194 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Evaluating the Effectiveness of Fish Oil Supplements at Reducing the Recurrence of Atrial Fibrillation
NCT00552084 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating the Relationship Between Fatty Acids and Heart Disease
NCT00404872 ·Status: COMPLETED
-
Low-Fat Fish Oil Diet for Prostate Cancer Prevention
NCT00798876 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study of Omega-3 Fatty Acids in Dialysis Patients
NCT01002118 ·Status: TERMINATED ·Phase: NA
-
Omega 3 Fatty Acids and Atrial Fibrillation
NCT00508248 ·Status: WITHDRAWN ·Phase: NA
-
Fish Oil and Inflammation in Overweight Subjects
NCT00885053 ·Status: COMPLETED ·Phase: NA
-
An Evaluation of Omega-3 Fatty Acid
NCT03017651 ·Status: COMPLETED ·Phase: PHASE1
-
The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes
NCT00360217 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega-3 Fatty Acids on Markers of Inflammation
NCT01129050 ·Status: COMPLETED ·Phase: NA
-
Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
NCT00935766 ·Status: TERMINATED ·Phase: PHASE3
-
Cardioprotective Effects of Omega-3 Fatty Acids Supplementation in Healthy Older Subjects Exposed to Air Pollution Particles
NCT01442480 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study Regarding the Beneficial Effects of Omega-3 Fatty Acids on Cardiometabolic Health
NCT02042274 ·Status: COMPLETED ·Phase: NA
-
Intervention With Omega Fatty Acids in High-risk Patients
NCT02647333 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of 12 wk of Omega-3 FA Supplementation on Metabolic and Physical Health Parameters in Older Adults
NCT01734538 ·Status: UNKNOWN ·Phase: NA
-
Cardiometabolic Benefits of Omega-3 Polyunsaturated Fatty Acids
NCT03378232 ·Status: COMPLETED ·Phase: NA
-
Nutrition Intervention to Decrease Symptoms in Patients With Heart Failure
NCT01733017 ·Status: COMPLETED ·Phase: PHASE2
-
Personalized Nutrition in Young Adults: The Ability of Genetic Information to Motivate Changes in Omega-3 Consumption
NCT02829138 ·Status: COMPLETED ·Phase: NA
-
Dose Response Effects of Marine Omega-3 Fatty Acids on Inflammation
NCT01078909 ·Status: COMPLETED ·Phase: PHASE3